1. Home
  2. NVCR vs DAN Comparison

NVCR vs DAN Comparison

Compare NVCR & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • DAN
  • Stock Information
  • Founded
  • NVCR 2000
  • DAN 1904
  • Country
  • NVCR Switzerland
  • DAN United States
  • Employees
  • NVCR N/A
  • DAN N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • DAN Auto Parts:O.E.M.
  • Sector
  • NVCR Health Care
  • DAN Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • DAN Nasdaq
  • Market Cap
  • NVCR 1.9B
  • DAN 2.1B
  • IPO Year
  • NVCR 2015
  • DAN N/A
  • Fundamental
  • Price
  • NVCR $19.11
  • DAN $16.64
  • Analyst Decision
  • NVCR Buy
  • DAN Buy
  • Analyst Count
  • NVCR 6
  • DAN 7
  • Target Price
  • NVCR $32.83
  • DAN $17.83
  • AVG Volume (30 Days)
  • NVCR 941.3K
  • DAN 1.6M
  • Earning Date
  • NVCR 07-24-2025
  • DAN 04-30-2025
  • Dividend Yield
  • NVCR N/A
  • DAN 2.40%
  • EPS Growth
  • NVCR N/A
  • DAN N/A
  • EPS
  • NVCR N/A
  • DAN N/A
  • Revenue
  • NVCR $621,711,000.00
  • DAN $9,901,000,000.00
  • Revenue This Year
  • NVCR $5.56
  • DAN N/A
  • Revenue Next Year
  • NVCR $9.15
  • DAN $4.02
  • P/E Ratio
  • NVCR N/A
  • DAN N/A
  • Revenue Growth
  • NVCR 18.27
  • DAN N/A
  • 52 Week Low
  • NVCR $14.17
  • DAN $7.58
  • 52 Week High
  • NVCR $34.13
  • DAN $17.25
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 58.46
  • DAN 63.65
  • Support Level
  • NVCR $18.66
  • DAN $15.59
  • Resistance Level
  • NVCR $20.06
  • DAN $17.25
  • Average True Range (ATR)
  • NVCR 0.86
  • DAN 0.58
  • MACD
  • NVCR 0.19
  • DAN -0.01
  • Stochastic Oscillator
  • NVCR 71.98
  • DAN 63.25

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About DAN Dana Incorporated

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

Share on Social Networks: